Adding an extra 10 to 20 healthy years on your life is one of the most valuable objectives we can offer you. In this webinar, Peter sits down with Dr. David Karow, CEO of Human Longevity Inc. for a discussion about the future of healthcare - the potential to catch disease at stage-zero or stage-one while it is still curable.
Historically, healthcare has been a reactive industry-- focused more on treatment AFTER your sick, than prevention. Imagine if you were able to digitize your entire body, and catch disease before it ever became life threatening. With the explosion of exponential technologies, the healthcare industry will move away from reactive ‘sickcare,' to preventative healthcare, ultimately making humans the CEOs of their own health.
In this hour long discussion, they discuss the impact that exponential technologies will have on human longevity in the next decade. More importantly, what you can do TODAY to ensure that you live a happy, long, and healthy life.
During this webinar, they touch on the following:
The latest breakthroughs in healthcare and what they mean for you.
Tips for how you can take control of your own health and maximize your longevity.
Your questions for Dr. Karow
Enjoy!
Up Next in Health and Longevity
-
Divya Chander + Longevity of the MInd
Dr. Divya Chander is a physician and neuroscientist who trained at Harvard, UCSD, UCSF, and the Salk Institute.
She has been on the Anesthesiology Faculty at Stanford University since 2008 and Neuromedicine Faculty at Singularity University since 2010.
In the operating room, she applies EEG tec...
-
Aubrey de Grey + Roadmap to End Aging
Dr. Aubrey de Grey is an English author and biomedical gerontologist. He is the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics, Inc.
He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985...
-
Laura Deming + The Longevity Fund
Laura Deming is the founder and full-time partner at The Longevity Fund, an early stage venture capital fund backing companies which target the aging process to treat disease, with investments in gene editing, small molecule therapeutics, and novel methods to treat disease.
From a young age, Ms....
